North American Crop Protection Chemicals Market 2017-2021 – Industry Consolidation will Impact Market Dynamics


North American Crop Protection Chemicals Market 2017-2021 – Industry Consolidation will Impact Market Dynamics

PR Newswire

DUBLIN, July 24, 2017 /PRNewswire/ —

The “North American Crop Protection Chemicals Market, Forecast to 2021” report has been added to Research and Markets’ offering.


This research service identifies the major industry drivers and restraints as well as the regulatory, product, market, and technology trends in the crop protection chemicals market. Growth in the crop protection chemicals market is expected to be predominantly driven by increased adoption rates for biopesticides owing to increased demand for organic food, lower developmental costs, less strict regulatory approval procedures, and a stringent regulatory environment, which increases the focus of agrochemical companies on biopesticides as they are a solution to overcome pest resistance to chemical pesticides.

Factors that stimulate the overall unit shipment and revenue growth of this market are increasing population and higher food demand, decreasing arable land, increasing herbicide resistance (which necessitates the use on different chemistries), increased demand for biofuels, and in addition, manufacturers contributing to the market with new product innovations, which claim to be safer for the environment with higher efficiency.

Technological innovations by manufacturers (such as nanopesticides that offer controlled pesticide release), exploration of epigenetics to develop promising new fungicide molecules, and the advent of digital farming tools with precise data from farms that can optimize the volume consumption of various crop protection chemicals are some market trends expected to aid in achieving superior quality products and improved application techniques. For instance, SIMPAS by AMVAC and Bayer CropScience is conducting R&D to develop software to aid precision in agriculture by optimizing application volumes of crop protection chemicals.

Key questions this study will answer:

– Is the market growing? How long will it continue to grow, and at what rate?

– What technology, product, and regulatory trends are seen in the market?

– How are the major mergers and acquisitions (M&A) impacting the crop protection market?

– Are the products meeting customer needs or is additional development needed?

– What are the key drivers for crop protection chemicals market growth?

Key Topics Covered:

1. Executive Summary

2. Market Overview

3. Market Trends

4. Forecasts and Trends-Total Crop Protection Chemicals Market

5. Competitive Analysis-Total Crop Protection Chemicals

6. Growth Opportunities and Companies to Action

7. Mega Trends and Industry Convergence Implications

8. Drivers and Restraints-Synthetic Pesticides Market

9. Synthetic Pesticides Market Analysis

10. Herbicide Market Analysis

11. Insecticide Market Analysis

12. Fungicide Market Analysis

13. Drivers and Restraints-Biopesticides Market

14. Biopesticide Market Analysis

15. Bioherbicide Market

16. Bioinsecticide Market

17. Biofungicide Market

18. The Last Word

19. Appendix

Companies Mentioned

– Adama


– Basf

– Bayer

– Certis USA

– China National Chemical Corp


– Dupont


– Monsanto

– Nippon Soda

– Novosymes

– Nufarm

– Sumitomo Chemical

– Syngenta

– Valent Biosciences

For more information about this report visit

Media Contact:

Laura Wood, Senior Manager

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


View original content:—industry-consolidation-will-impact-market-dynamics-300492816.html

SOURCE Research and Markets

Oregrown™ Launches PAX® Era Device and PAX Era Pods in Oregon


Oregrown™ Launches PAX® Era Device and PAX Era Pods in Oregon

Available exclusively at the Oregrown Flagship Dispensary in beautiful Downtown Bend, Oregon.

PR Newswire

BEND, Ore., July 24, 2017 /PRNewswire/ – Oregrown Industries, Inc. announced today that the company has launched the revolutionary PAX® Era vaporizer at its flagship store in Downtown Bend and throughout the state of Oregon.

Oregrown™ Launches PAX® Era  Device and PAX Era Pods in Oregon

“Simply put, the PAX Era is a game changer,” said Oregrown™ co-founder Aviv Hadar.

The PAX Era is a smart, lightweight and pocket-sized device that connects to the user’s mobile phone via a robust mobile app. The no-button interface provides instant response with extremely precise temperature control for preferred vapor amount and flavor profile.

“We tried to make sure that every corner of the state got a chance to try this incredible product,” said Hadar. “You can get your hands on a PAX Era and our delicious pods in the valley (Portland, Eugene), on the coast (Astoria), in Eastern Oregon (Huntington), in Southern Oregon (Medford), and of course at the Oregrown Flagship in Central Oregon.”

Oregrown is once again collaborating with their close friends over at EVOLVD to develop new and unique formulations specifically for the PAX Era. The team is launching with a delicious line of flavors to suit any mood or occasion. Pod flavors include Oregrown’s premier Oregon Afghani, Mango Haze, CBD-enriched Pacific Mint, Cookies and Kush and Chem Diesel.

“EVOLVD’s Artisn™ extraction methodologies produce an extract that is extremely true to the plant,” said Hadar. “The best oil in the state. Beautiful, delicious and clean. We knew right away that this technology would be a perfect fit for Oregrown and EVOLVD.”

“I really admire the way Oregrown focuses on organically cultivating core genetics and landrace strains,” said EVOLVD founder Marley Bankoff. “It has been a pleasure to work with such magnificent flavors throughout the extraction process,” Bankoff says. “We make a great team.”

Featuring exclusive flavors and promotions, the PAX Era is now available at the Oregrown Flagship, and will be available statewide through their retail partners within the next two weeks. Oregrown’s Initial retail partners include Amazon Organics in Eugene, Five Zero Trees in Portland and Astoria, Hotbox Farms in Huntington, and Fireside Dispensary in Medford.

For media inquires:

Allie Trapani


Oregrown Logo (PRNewsFoto/Oregrown)

View original content with multimedia:

SOURCE Oregrown Industries

Independence Blue Cross and Jefferson Health commit to building a healthier Philadelphia and bringing care closer to home through innovation


Independence Blue Cross (Independence) and Jefferson Health, two organizations that already work hand-in-hand on an Innovation Collaboration program, have signed a five-year agreement that will marshal resources from both organizations to transform the access, quality, experience and cost of the care members and patients receive. The agreement also signifies Jefferson Health officially joining the Independence Facilitated Health Networks (FHN) model — a collaborative approach that is gaining regional and national traction for bringing health insurers and health systems together to improve the quality and lower the costs of care for members and patients. Jefferson Health has expanded in recent years to include Abington Health, Aria Health, and has signed a definitive agreement with Kennedy Health, creating a broad provider network blanketing the Greater Philadelphia area.

“We are proud to have a new, long-term agreement with Jefferson Health, an institution that shares our drive to transform health care in this region and across the country,” said Daniel J. Hilferty, president and CEO at Independence. “The agreement reflects a strong, innovative partnership and demonstrates the bold leadership that has made Jefferson a national leader in delivering improved patient care and health outcomes.”

The agreement and Jefferson Health’s participation in the Independence FHN model commits the organizations to work together to provide well-coordinated team-based care. The kind of care that will improve access for Independence members and Jefferson Health patients through innovative technology that monitors progress and allows patients to interact with a caring team of professionals regardless of whether the patient is at home, in the hospital or another setting such as JeffConnect® — the largest specialty telehealth initiative in the region. This approach is aimed at improving clinical outcomes, preventing the need for avoidable readmissions and reducing care costs.

The two organizations also have the opportunity to expand on the Innovation Collaboration they established together in June 2015, whose initiatives — like the Independence-Jefferson hack-a-thons — have already yielded implementable ideas using augmented intelligence, predictive data analytics, virtual reality, and drone technology. Each of these efforts has the same end goal of improving the health of members, patients, and the community-at-large.

“We have a unique opportunity in this new, expanded relationship with Independence to achieve our vision of reimagining health care, education and discovery to create value and improve lives. Jefferson is committed to bringing tomorrow’s health care to Philadelphia today and we have an innovative partner in Independence,” said Stephen K. Klasko, MD, MBA, president and CEO at Thomas Jefferson University and Jefferson Health. “We will leverage Jefferson Health’s unique strengths, such as our unique partnership with GE, our expanding telehealth program and our best-in-class physicians, nurses and employees to enhance patient and member access to better health care.”

Building on the Innovation Collaboration, the two organizations are now in talks to design initiatives for a healthier Philadelphia including:

  • Enhanced and more broadly implemented telehealth and virtual care services, bringing Jefferson care closer to home. This includes a number of initiatives like JeffConnect® virtual triage, which will guide patients to the best setting for unscheduled care, and virtual rounds that allow family members to communicate directly with the patient and providers in the hospital. Teams are also exploring a “hospital without beds” that allows doctors and health systems to care for patients remotely round-the-clock while also reducing the cost of care. These initiatives are supplemented with diagnostic services that connect patients with Jefferson Health doctors — anytime, anywhere — through their cell phone, tablet or computer with a webcam.
  • An agreement to assess integrative medicine to help combat specific health issues. This will involve Independence working with Jefferson’s Marcus Institute of Integrative Health on issues like behavioral health and pain management to support and treat patients battling opioid addiction.
  • Disease management programs to address common, costly, yet manageable health issues. This includes a digital diabetes management program with Jefferson Health and other health partners to create new, cost-effective ways of addressing the disease which can drastically affect health and quality of life.
  • Comprehensive programs to address health disparities among cancer patients. Independence and Jefferson Health will explore leveraging the Sidney Kimmel Cancer Center's expertise to address cancer disparities in Philadelphia and beyond, through building on the Center's Men's Genetic Risk Clinic and using genetics to match the right patient to the right therapy for addition cancer diagnoses.

The agreement, effective September 1, 2017, will include the following facilities and physician practice groups recognized for excellence in patient care:

  • Thomas Jefferson University Hospital (TJUH) and TJUH’s Methodist Hospital
  • Abington Hospital and Abington – Lansdale Hospital
  • Jefferson University Physicians
  • Jefferson Urgent Care
  • Jefferson University Radiology Associates
  • Abington Health Physicians
  • Aria Health
  • Aria Health Physicians

About Independence Blue Cross

Independence Blue Cross is the leading health insurance organization in southeastern Pennsylvania. With our affiliates, we serve more than 8.5 million people in 25 states and the District of Columbia, including more than 2.5 million in the region. For almost 80 years, we have been enhancing the health and well-being of the people and communities we serve by delivering innovative and competitively priced health care products and services; pioneering new ways to reward doctors, hospitals, and other health care professionals for coordinated, quality care; and supporting programs and events that promote wellness. To learn more, visit Connect with us on Facebook at and on Twitter at @ibx. Independence Blue Cross is an independent licensee of the Blue Cross and Blue Shield Association.

About Jefferson

Jefferson, through its academic and clinical entities of Thomas Jefferson University and Jefferson Health, including Abington Health and Aria Health, is reimagining health care for the greater Philadelphia region and southern New Jersey. Jefferson has 23,000 people dedicated to providing the highest-quality, compassionate clinical care for patients, educating the health professionals of tomorrow, and discovering new treatments and therapies to define the future of care. With a university and hospital that date back to 1824, today Jefferson is comprised of six colleges, nine hospitals, 35 outpatient and urgent care locations, and a multitude of physician practices throughout the region, serving more than 100,000 inpatients, 373,000 emergency patients and 2.2 million outpatients annually.


Read the full story at